Eyal Peleg

BioGenCell Ltd. is an Israeli company based at Laniado Hospital in Israel that is dedicated to improving the lives of patients suffering from degenerative microvascular diseases. The company is based in Netanya, Israel. The company aims to extend its reach to address a wider range of vascular and other diseases in the future. BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments since its inception in 2008. The company's groundbreaking tract technology uses a patient's own blood as personalized medicine. BioGenCell's personalized treatments are produced from the patients' own cells, mimicking the body's natural processes. The company was founded by Michael Belkin, Yael Porat, and Eyal Peleg, and Yael Porat has been the CEO since incorporation.

BioGenCell Ltd. is an Israeli company based at Laniado Hospital in Israel that is dedicated to improving the lives of patients suffering from degenerative microvascular diseases. The company is based in Netanya, Israel. The company aims to extend its reach to address a wider range of vascular and other diseases in the future. BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments since its inception in 2008. The company's groundbreaking tract technology uses a patient's own blood as personalized medicine. BioGenCell's personalized treatments are produced from the patients' own cells, mimicking the body's natural processes. The company was founded by Michael Belkin, Yael Porat, and Eyal Peleg, and Yael Porat has been the CEO since incorporation.

BioGenCell Ltd. is an Israeli company based at Laniado Hospital in Israel that is dedicated to improving the lives of patients suffering from degenerative microvascular diseases. The company is based in Netanya, Israel. The company aims to extend its reach to address a wider range of vascular and other diseases in the future. BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments since its inception in 2008. The company's groundbreaking tract technology uses a patient's own blood as personalized medicine. BioGenCell's personalized treatments are produced from the patients' own cells, mimicking the body's natural processes. The company was founded by Michael Belkin, Yael Porat, and Eyal Peleg, and Yael Porat has been the CEO since incorporation.

BioGenCell Ltd. is an Israeli company based at Laniado Hospital in Israel that is dedicated to improving the lives of patients suffering from degenerative microvascular diseases. The company is based in Netanya, Israel. The company aims to extend its reach to address a wider range of vascular and other diseases in the future. BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments since its inception in 2008. The company's groundbreaking tract technology uses a patient's own blood as personalized medicine. BioGenCell's personalized treatments are produced from the patients' own cells, mimicking the body's natural processes. The company was founded by Michael Belkin, Yael Porat, and Eyal Peleg, and Yael Porat has been the CEO since incorporation.

BioGenCell Ltd. is an Israeli company based at Laniado Hospital in Israel that is dedicated to improving the lives of patients suffering from degenerative microvascular diseases. The company is based in Netanya, Israel. The company aims to extend its reach to address a wider range of vascular and other diseases in the future. BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments since its inception in 2008. The company's groundbreaking tract technology uses a patient's own blood as personalized medicine. BioGenCell's personalized treatments are produced from the patients' own cells, mimicking the body's natural processes. The company was founded by Michael Belkin, Yael Porat, and Eyal Peleg, and Yael Porat has been the CEO since incorporation.